Treating diabetic nephropathy--are there only economic issues?

N Engl J Med. 2004 Nov 4;351(19):1934-6. doi: 10.1056/NEJMp048254. Epub 2004 Oct 31.

Author

William E Mitch¹

Affiliation

¹ Renal Division, University of Texas Medical Branch, Galveston, USA

PMID: 15516698
DOI: 10.1056/NEJMp048254

No abstract available

Publication types

Comment

MeSH terms

Albuminuria / prevention & control
Angiotensin Receptor Antagonists*
Angiotensin-Converting Enzyme Inhibitors / economics
Angiotensin-Converting Enzyme Inhibitors / therapeutic use*
Calcium Channel Blockers / economics
Calcium Channel Blockers / therapeutic use*
Diabetes Mellitus, Type 2 / drug therapy*
Diabetic Nephropathies / drug therapy*
Diabetic Nephropathies / economics*
Humans
Hypertension / drug therapy*
United States

Substances

Angiotensin Receptor Antagonists
Angiotensin-Converting Enzyme Inhibitors
Calcium Channel Blockers